nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—HTR2C—Sorafenib—thyroid cancer	0.119	0.215	CbGbCtD
Perphenazine—CYP2B6—Sorafenib—thyroid cancer	0.0738	0.133	CbGbCtD
Perphenazine—CYP2C8—Sorafenib—thyroid cancer	0.0559	0.101	CbGbCtD
Perphenazine—CYP2C19—Sorafenib—thyroid cancer	0.0469	0.0847	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—thyroid cancer	0.0448	0.0808	CbGbCtD
Perphenazine—CYP1A2—Sorafenib—thyroid cancer	0.0432	0.0781	CbGbCtD
Perphenazine—CYP2C9—Sorafenib—thyroid cancer	0.039	0.0704	CbGbCtD
Perphenazine—CYP3A4—Vandetanib—thyroid cancer	0.0376	0.0679	CbGbCtD
Perphenazine—CYP2D6—Sorafenib—thyroid cancer	0.0356	0.0644	CbGbCtD
Perphenazine—CYP3A4—Sorafenib—thyroid cancer	0.0227	0.0409	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—thyroid cancer	0.0216	0.0391	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—thyroid cancer	0.0137	0.0248	CbGbCtD
Perphenazine—Brain oedema—Vandetanib—thyroid cancer	0.0125	0.0749	CcSEcCtD
Perphenazine—Sudden death—Vandetanib—thyroid cancer	0.00698	0.0418	CcSEcCtD
Perphenazine—Glaucoma—Vandetanib—thyroid cancer	0.00474	0.0284	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00331	0.0198	CcSEcCtD
Perphenazine—Faecaloma—Epirubicin—thyroid cancer	0.00311	0.0187	CcSEcCtD
Perphenazine—Faecalith—Epirubicin—thyroid cancer	0.00311	0.0187	CcSEcCtD
Perphenazine—Faecaloma—Doxorubicin—thyroid cancer	0.00288	0.0173	CcSEcCtD
Perphenazine—Faecalith—Doxorubicin—thyroid cancer	0.00288	0.0173	CcSEcCtD
Perphenazine—Hypoglycaemia—Vandetanib—thyroid cancer	0.00266	0.0159	CcSEcCtD
Perphenazine—Lethargy—Vandetanib—thyroid cancer	0.00264	0.0159	CcSEcCtD
Perphenazine—Cardiac arrest—Vandetanib—thyroid cancer	0.00246	0.0148	CcSEcCtD
Perphenazine—Dysphagia—Vandetanib—thyroid cancer	0.00224	0.0134	CcSEcCtD
Perphenazine—Gynaecomastia—Sorafenib—thyroid cancer	0.00215	0.0129	CcSEcCtD
Perphenazine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00204	0.0123	CcSEcCtD
Perphenazine—Hyperglycaemia—Vandetanib—thyroid cancer	0.00202	0.0121	CcSEcCtD
Perphenazine—Eczema—Sorafenib—thyroid cancer	0.00195	0.0117	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00185	0.0111	CcSEcCtD
Perphenazine—Bradycardia—Vandetanib—thyroid cancer	0.00183	0.0109	CcSEcCtD
Perphenazine—CALM2—neck—thyroid cancer	0.00166	0.0475	CbGeAlD
Perphenazine—CALM1—neck—thyroid cancer	0.00165	0.0473	CbGeAlD
Perphenazine—CALM3—saliva-secreting gland—thyroid cancer	0.00165	0.0472	CbGeAlD
Perphenazine—HTR7—neck—thyroid cancer	0.00161	0.0462	CbGeAlD
Perphenazine—Dysphagia—Sorafenib—thyroid cancer	0.00151	0.00906	CcSEcCtD
Perphenazine—Muscle spasms—Vandetanib—thyroid cancer	0.0015	0.00899	CcSEcCtD
Perphenazine—Vision blurred—Vandetanib—thyroid cancer	0.00147	0.00882	CcSEcCtD
Perphenazine—HTR6—head—thyroid cancer	0.00147	0.042	CbGeAlD
Perphenazine—AOX1—trachea—thyroid cancer	0.00141	0.0404	CbGeAlD
Perphenazine—Loss of consciousness—Vandetanib—thyroid cancer	0.00137	0.00822	CcSEcCtD
Perphenazine—Cough—Vandetanib—thyroid cancer	0.00136	0.00816	CcSEcCtD
Perphenazine—Convulsion—Vandetanib—thyroid cancer	0.00135	0.0081	CcSEcCtD
Perphenazine—Hypertension—Vandetanib—thyroid cancer	0.00135	0.00808	CcSEcCtD
Perphenazine—Jaundice—Sorafenib—thyroid cancer	0.00131	0.00787	CcSEcCtD
Perphenazine—Dry mouth—Vandetanib—thyroid cancer	0.0013	0.00779	CcSEcCtD
Perphenazine—CALM2—saliva-secreting gland—thyroid cancer	0.00129	0.0371	CbGeAlD
Perphenazine—CALM1—saliva-secreting gland—thyroid cancer	0.00129	0.0369	CbGeAlD
Perphenazine—CALM3—trachea—thyroid cancer	0.00127	0.0364	CbGeAlD
Perphenazine—Infection—Vandetanib—thyroid cancer	0.00127	0.00758	CcSEcCtD
Perphenazine—Insomnia—Vandetanib—thyroid cancer	0.00115	0.0069	CcSEcCtD
Perphenazine—Dyspnoea—Vandetanib—thyroid cancer	0.00114	0.00681	CcSEcCtD
Perphenazine—AOX1—thyroid gland—thyroid cancer	0.00112	0.032	CbGeAlD
Perphenazine—Decreased appetite—Vandetanib—thyroid cancer	0.00111	0.00664	CcSEcCtD
Perphenazine—Glycosuria—Epirubicin—thyroid cancer	0.0011	0.00658	CcSEcCtD
Perphenazine—DRD1—head—thyroid cancer	0.00109	0.0312	CbGeAlD
Perphenazine—Pain—Vandetanib—thyroid cancer	0.00109	0.00653	CcSEcCtD
Perphenazine—Constipation—Vandetanib—thyroid cancer	0.00109	0.00653	CcSEcCtD
Perphenazine—Blood disorder—Epirubicin—thyroid cancer	0.00107	0.00639	CcSEcCtD
Perphenazine—Liver injury—Epirubicin—thyroid cancer	0.00106	0.00634	CcSEcCtD
Perphenazine—Erythema—Sorafenib—thyroid cancer	0.00105	0.00631	CcSEcCtD
Perphenazine—Glycosuria—Doxorubicin—thyroid cancer	0.00102	0.00609	CcSEcCtD
Perphenazine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00101	0.00607	CcSEcCtD
Perphenazine—Amenorrhoea—Epirubicin—thyroid cancer	0.00101	0.00607	CcSEcCtD
Perphenazine—Muscle spasms—Sorafenib—thyroid cancer	0.00101	0.00607	CcSEcCtD
Perphenazine—Body temperature increased—Vandetanib—thyroid cancer	0.00101	0.00603	CcSEcCtD
Perphenazine—HTR2A—neck—thyroid cancer	0.00101	0.0288	CbGeAlD
Perphenazine—CALM3—thyroid gland—thyroid cancer	0.00101	0.0288	CbGeAlD
Perphenazine—CALM2—trachea—thyroid cancer	0.000999	0.0286	CbGeAlD
Perphenazine—CALM1—trachea—thyroid cancer	0.000994	0.0285	CbGeAlD
Perphenazine—Blood disorder—Doxorubicin—thyroid cancer	0.000986	0.00591	CcSEcCtD
Perphenazine—Liver injury—Doxorubicin—thyroid cancer	0.000979	0.00587	CcSEcCtD
Perphenazine—HTR7—trachea—thyroid cancer	0.000971	0.0278	CbGeAlD
Perphenazine—Angioedema—Sorafenib—thyroid cancer	0.000962	0.00577	CcSEcCtD
Perphenazine—Dyskinesia—Epirubicin—thyroid cancer	0.000947	0.00568	CcSEcCtD
Perphenazine—Syncope—Sorafenib—thyroid cancer	0.000944	0.00566	CcSEcCtD
Perphenazine—Leukopenia—Sorafenib—thyroid cancer	0.000942	0.00565	CcSEcCtD
Perphenazine—Dysarthria—Epirubicin—thyroid cancer	0.000941	0.00564	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000937	0.00562	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—thyroid cancer	0.000937	0.00562	CcSEcCtD
Perphenazine—Loss of consciousness—Sorafenib—thyroid cancer	0.000925	0.00555	CcSEcCtD
Perphenazine—Cough—Sorafenib—thyroid cancer	0.000919	0.00551	CcSEcCtD
Perphenazine—Hypertension—Sorafenib—thyroid cancer	0.000909	0.00545	CcSEcCtD
Perphenazine—Pruritus—Vandetanib—thyroid cancer	0.000901	0.0054	CcSEcCtD
Perphenazine—Hepatocellular injury—Epirubicin—thyroid cancer	0.00089	0.00533	CcSEcCtD
Perphenazine—Dermatitis contact—Epirubicin—thyroid cancer	0.00088	0.00527	CcSEcCtD
Perphenazine—Abnormal dreams—Epirubicin—thyroid cancer	0.00088	0.00527	CcSEcCtD
Perphenazine—Dry mouth—Sorafenib—thyroid cancer	0.000877	0.00525	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—thyroid cancer	0.000876	0.00525	CcSEcCtD
Perphenazine—Diarrhoea—Vandetanib—thyroid cancer	0.000871	0.00522	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—thyroid cancer	0.000871	0.00522	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000864	0.00518	CcSEcCtD
Perphenazine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000859	0.00515	CcSEcCtD
Perphenazine—Infection—Sorafenib—thyroid cancer	0.000854	0.00512	CcSEcCtD
Perphenazine—HTR2C—head—thyroid cancer	0.000847	0.0243	CbGeAlD
Perphenazine—Shock—Sorafenib—thyroid cancer	0.000845	0.00507	CcSEcCtD
Perphenazine—Dizziness—Vandetanib—thyroid cancer	0.000842	0.00505	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000824	0.00494	CcSEcCtD
Perphenazine—Anorexia—Sorafenib—thyroid cancer	0.000819	0.00491	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—thyroid cancer	0.000814	0.00488	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—thyroid cancer	0.000814	0.00488	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.0008	0.00479	CcSEcCtD
Perphenazine—Headache—Vandetanib—thyroid cancer	0.000798	0.00478	CcSEcCtD
Perphenazine—CALM2—thyroid gland—thyroid cancer	0.00079	0.0226	CbGeAlD
Perphenazine—CALM1—thyroid gland—thyroid cancer	0.000786	0.0225	CbGeAlD
Perphenazine—Dyspnoea—Sorafenib—thyroid cancer	0.000766	0.00459	CcSEcCtD
Perphenazine—Decreased appetite—Sorafenib—thyroid cancer	0.000747	0.00448	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—thyroid cancer	0.000736	0.00441	CcSEcCtD
Perphenazine—Constipation—Sorafenib—thyroid cancer	0.000735	0.0044	CcSEcCtD
Perphenazine—Pain—Sorafenib—thyroid cancer	0.000735	0.0044	CcSEcCtD
Perphenazine—HRH1—trachea—thyroid cancer	0.000725	0.0208	CbGeAlD
Perphenazine—Eczema—Epirubicin—thyroid cancer	0.000719	0.00431	CcSEcCtD
Perphenazine—HTR1A—head—thyroid cancer	0.000713	0.0204	CbGeAlD
Perphenazine—ADRA2A—trachea—thyroid cancer	0.000712	0.0204	CbGeAlD
Perphenazine—CALM2—head—thyroid cancer	0.000701	0.0201	CbGeAlD
Perphenazine—CALM1—head—thyroid cancer	0.000698	0.02	CbGeAlD
Perphenazine—AOX1—lymph node—thyroid cancer	0.000694	0.0199	CbGeAlD
Perphenazine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000685	0.0041	CcSEcCtD
Perphenazine—Urticaria—Sorafenib—thyroid cancer	0.000683	0.00409	CcSEcCtD
Perphenazine—HTR7—head—thyroid cancer	0.000682	0.0195	CbGeAlD
Perphenazine—Photosensitivity—Doxorubicin—thyroid cancer	0.000681	0.00408	CcSEcCtD
Perphenazine—Body temperature increased—Sorafenib—thyroid cancer	0.000679	0.00407	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000668	0.004	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—thyroid cancer	0.000665	0.00399	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000662	0.00397	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—thyroid cancer	0.000659	0.00395	CcSEcCtD
Perphenazine—DRD2—head—thyroid cancer	0.000644	0.0185	CbGeAlD
Perphenazine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000634	0.0038	CcSEcCtD
Perphenazine—Hypersensitivity—Sorafenib—thyroid cancer	0.000633	0.00379	CcSEcCtD
Perphenazine—CALM3—lymph node—thyroid cancer	0.000625	0.0179	CbGeAlD
Perphenazine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000618	0.0037	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—thyroid cancer	0.000614	0.00368	CcSEcCtD
Perphenazine—CYP1A2—thyroid gland—thyroid cancer	0.000613	0.0176	CbGeAlD
Perphenazine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000613	0.00367	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—thyroid cancer	0.00061	0.00366	CcSEcCtD
Perphenazine—Pruritus—Sorafenib—thyroid cancer	0.000608	0.00364	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—thyroid cancer	0.000607	0.00364	CcSEcCtD
Perphenazine—HTR2A—trachea—thyroid cancer	0.000606	0.0173	CbGeAlD
Perphenazine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00059	0.00354	CcSEcCtD
Perphenazine—Diarrhoea—Sorafenib—thyroid cancer	0.000588	0.00352	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—thyroid cancer	0.00057	0.00342	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000568	0.00341	CcSEcCtD
Perphenazine—Dizziness—Sorafenib—thyroid cancer	0.000568	0.00341	CcSEcCtD
Perphenazine—ADRA2A—thyroid gland—thyroid cancer	0.000563	0.0161	CbGeAlD
Perphenazine—Ataxia—Doxorubicin—thyroid cancer	0.000562	0.00337	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—thyroid cancer	0.000558	0.00335	CcSEcCtD
Perphenazine—Asthma—Epirubicin—thyroid cancer	0.000558	0.00335	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—thyroid cancer	0.000553	0.00331	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000546	0.00327	CcSEcCtD
Perphenazine—Headache—Sorafenib—thyroid cancer	0.000538	0.00323	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—thyroid cancer	0.00053	0.00318	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—thyroid cancer	0.000527	0.00316	CcSEcCtD
Perphenazine—CYP2B6—head—thyroid cancer	0.000521	0.0149	CbGeAlD
Perphenazine—Asthma—Doxorubicin—thyroid cancer	0.000517	0.0031	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—thyroid cancer	0.000517	0.0031	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—thyroid cancer	0.000512	0.00307	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00051	0.00305	CcSEcCtD
Perphenazine—HRH1—head—thyroid cancer	0.000509	0.0146	CbGeAlD
Perphenazine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000504	0.00302	CcSEcCtD
Perphenazine—ADRA2A—head—thyroid cancer	0.0005	0.0143	CbGeAlD
Perphenazine—Drowsiness—Epirubicin—thyroid cancer	0.000498	0.00298	CcSEcCtD
Perphenazine—CALM2—lymph node—thyroid cancer	0.000491	0.0141	CbGeAlD
Perphenazine—Pancytopenia—Doxorubicin—thyroid cancer	0.000491	0.00294	CcSEcCtD
Perphenazine—CALM1—lymph node—thyroid cancer	0.000489	0.014	CbGeAlD
Perphenazine—Jaundice—Epirubicin—thyroid cancer	0.000485	0.00291	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000472	0.00283	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000466	0.00279	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—thyroid cancer	0.000465	0.00278	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—thyroid cancer	0.000461	0.00276	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—thyroid cancer	0.000455	0.00273	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—thyroid cancer	0.000449	0.00269	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000445	0.00267	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—thyroid cancer	0.00044	0.00264	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00043	0.00258	CcSEcCtD
Perphenazine—HTR2A—head—thyroid cancer	0.000425	0.0122	CbGeAlD
Perphenazine—Bradycardia—Doxorubicin—thyroid cancer	0.000421	0.00252	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000411	0.00247	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000407	0.00244	CcSEcCtD
Perphenazine—Erythema—Epirubicin—thyroid cancer	0.000389	0.00233	CcSEcCtD
Perphenazine—CYP2D6—head—thyroid cancer	0.000387	0.0111	CbGeAlD
Perphenazine—Muscle spasms—Epirubicin—thyroid cancer	0.000374	0.00224	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—thyroid cancer	0.000367	0.0022	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—thyroid cancer	0.00036	0.00216	CcSEcCtD
Perphenazine—Agitation—Epirubicin—thyroid cancer	0.000358	0.00214	CcSEcCtD
Perphenazine—HRH1—lymph node—thyroid cancer	0.000356	0.0102	CbGeAlD
Perphenazine—ADRA2A—lymph node—thyroid cancer	0.00035	0.01	CbGeAlD
Perphenazine—Syncope—Epirubicin—thyroid cancer	0.000349	0.00209	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—thyroid cancer	0.000348	0.00209	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—thyroid cancer	0.000346	0.00207	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—thyroid cancer	0.000342	0.00205	CcSEcCtD
Perphenazine—Cough—Epirubicin—thyroid cancer	0.00034	0.00203	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—thyroid cancer	0.000339	0.00203	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—thyroid cancer	0.000337	0.00202	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—thyroid cancer	0.000336	0.00201	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—thyroid cancer	0.000331	0.00198	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—thyroid cancer	0.000324	0.00194	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—thyroid cancer	0.000323	0.00193	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—thyroid cancer	0.000322	0.00193	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—thyroid cancer	0.00032	0.00192	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000318	0.0019	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000316	0.0019	CcSEcCtD
Perphenazine—Infection—Epirubicin—thyroid cancer	0.000315	0.00189	CcSEcCtD
Perphenazine—Cough—Doxorubicin—thyroid cancer	0.000314	0.00188	CcSEcCtD
Perphenazine—Shock—Epirubicin—thyroid cancer	0.000312	0.00187	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—thyroid cancer	0.000312	0.00187	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—thyroid cancer	0.000311	0.00186	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—thyroid cancer	0.00031	0.00186	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—thyroid cancer	0.000303	0.00181	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—thyroid cancer	0.0003	0.0018	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—thyroid cancer	0.000297	0.00178	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—thyroid cancer	0.000296	0.00178	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000294	0.00176	CcSEcCtD
Perphenazine—Infection—Doxorubicin—thyroid cancer	0.000292	0.00175	CcSEcCtD
Perphenazine—Shock—Doxorubicin—thyroid cancer	0.000289	0.00173	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—thyroid cancer	0.000287	0.00172	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—thyroid cancer	0.000287	0.00172	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—thyroid cancer	0.000283	0.0017	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—thyroid cancer	0.000282	0.00169	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—thyroid cancer	0.00028	0.00168	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—thyroid cancer	0.000276	0.00165	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—thyroid cancer	0.000275	0.00165	CcSEcCtD
Perphenazine—Pain—Epirubicin—thyroid cancer	0.000272	0.00163	CcSEcCtD
Perphenazine—Constipation—Epirubicin—thyroid cancer	0.000272	0.00163	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—thyroid cancer	0.000266	0.00159	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—thyroid cancer	0.000262	0.00157	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—thyroid cancer	0.000261	0.00157	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—thyroid cancer	0.000255	0.00153	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—thyroid cancer	0.000252	0.00151	CcSEcCtD
Perphenazine—Pain—Doxorubicin—thyroid cancer	0.000251	0.00151	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—thyroid cancer	0.000251	0.00151	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—thyroid cancer	0.000251	0.0015	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—thyroid cancer	0.000234	0.0014	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—thyroid cancer	0.000233	0.0014	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—thyroid cancer	0.000232	0.00139	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—thyroid cancer	0.000225	0.00135	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—thyroid cancer	0.000217	0.0013	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000216	0.0013	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—thyroid cancer	0.00021	0.00126	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—thyroid cancer	0.000208	0.00125	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—thyroid cancer	0.000201	0.0012	CcSEcCtD
Perphenazine—Headache—Epirubicin—thyroid cancer	0.000199	0.00119	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—thyroid cancer	0.000194	0.00116	CcSEcCtD
Perphenazine—Headache—Doxorubicin—thyroid cancer	0.000184	0.0011	CcSEcCtD
Perphenazine—CALM2—Hemostasis—TP53—thyroid cancer	1.92e-05	7.84e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—thyroid cancer	1.92e-05	7.84e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRG1—thyroid cancer	1.9e-05	7.78e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRG1—thyroid cancer	1.9e-05	7.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—HRAS—thyroid cancer	1.9e-05	7.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PPARG—thyroid cancer	1.88e-05	7.69e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.87e-05	7.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—KRAS—thyroid cancer	1.87e-05	7.63e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—KRAS—thyroid cancer	1.87e-05	7.63e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PTEN—thyroid cancer	1.86e-05	7.59e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PTEN—thyroid cancer	1.85e-05	7.58e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.85e-05	7.57e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.84e-05	7.5e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.84e-05	7.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—HRAS—thyroid cancer	1.84e-05	7.5e-05	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—HRAS—thyroid cancer	1.84e-05	7.5e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.82e-05	7.45e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—AKT1—thyroid cancer	1.81e-05	7.4e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—AKT1—thyroid cancer	1.81e-05	7.39e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.79e-05	7.33e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.79e-05	7.31e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.79e-05	7.3e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.78e-05	7.26e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TERT—thyroid cancer	1.77e-05	7.22e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	1.77e-05	7.22e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.77e-05	7.21e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PPARG—thyroid cancer	1.72e-05	7.02e-05	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.72e-05	7.02e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.71e-05	7e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TERT—thyroid cancer	1.71e-05	6.98e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TERT—thyroid cancer	1.71e-05	6.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HRAS—thyroid cancer	1.71e-05	6.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HIF1A—thyroid cancer	1.69e-05	6.9e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.69e-05	6.89e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.68e-05	6.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—AKT1—thyroid cancer	1.68e-05	6.85e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PPARG—thyroid cancer	1.66e-05	6.79e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PPARG—thyroid cancer	1.66e-05	6.79e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.66e-05	6.77e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CCND1—thyroid cancer	1.66e-05	6.77e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—NRAS—thyroid cancer	1.65e-05	6.76e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HRAS—thyroid cancer	1.65e-05	6.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HRAS—thyroid cancer	1.65e-05	6.75e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.65e-05	6.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HRAS—thyroid cancer	1.64e-05	6.7e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HIF1A—thyroid cancer	1.63e-05	6.68e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HIF1A—thyroid cancer	1.63e-05	6.68e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.63e-05	6.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—AKT1—thyroid cancer	1.62e-05	6.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—AKT1—thyroid cancer	1.62e-05	6.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTGS2—thyroid cancer	1.61e-05	6.59e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.6e-05	6.54e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PTEN—thyroid cancer	1.6e-05	6.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HRAS—thyroid cancer	1.59e-05	6.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HRAS—thyroid cancer	1.59e-05	6.48e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.57e-05	6.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTGS2—thyroid cancer	1.56e-05	6.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTGS2—thyroid cancer	1.56e-05	6.38e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	1.56e-05	6.37e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.54e-05	6.31e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.54e-05	6.29e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.53e-05	6.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PTEN—thyroid cancer	1.52e-05	6.23e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.52e-05	6.2e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.51e-05	6.18e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.51e-05	6.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—AKT1—thyroid cancer	1.51e-05	6.16e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PPARG—thyroid cancer	1.49e-05	6.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—NRAS—thyroid cancer	1.49e-05	6.08e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.48e-05	6.05e-05	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.48e-05	6.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PTEN—thyroid cancer	1.47e-05	6.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PTEN—thyroid cancer	1.47e-05	6.03e-05	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.47e-05	6e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—AKT1—thyroid cancer	1.46e-05	5.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—AKT1—thyroid cancer	1.46e-05	5.96e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—AKT1—thyroid cancer	1.45e-05	5.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—NRAS—thyroid cancer	1.44e-05	5.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—NRAS—thyroid cancer	1.44e-05	5.88e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NRAS—thyroid cancer	1.43e-05	5.83e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KRAS—thyroid cancer	1.43e-05	5.83e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KRAS—thyroid cancer	1.42e-05	5.82e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.42e-05	5.82e-05	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—AKT1—thyroid cancer	1.42e-05	5.8e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.42e-05	5.79e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTEN—thyroid cancer	1.41e-05	5.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.4e-05	5.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—AKT1—thyroid cancer	1.4e-05	5.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—AKT1—thyroid cancer	1.4e-05	5.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—BRAF—thyroid cancer	1.4e-05	5.72e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.39e-05	5.67e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.37e-05	5.62e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.37e-05	5.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTEN—thyroid cancer	1.36e-05	5.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTEN—thyroid cancer	1.36e-05	5.56e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NRAS—thyroid cancer	1.36e-05	5.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—BRAF—thyroid cancer	1.35e-05	5.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—BRAF—thyroid cancer	1.35e-05	5.53e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—thyroid cancer	1.35e-05	5.52e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.34e-05	5.48e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.33e-05	5.45e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.33e-05	5.45e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.33e-05	5.45e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NRAS—thyroid cancer	1.32e-05	5.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NRAS—thyroid cancer	1.32e-05	5.38e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.31e-05	5.36e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.31e-05	5.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—thyroid cancer	1.31e-05	5.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—thyroid cancer	1.31e-05	5.34e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.3e-05	5.3e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTEN—thyroid cancer	1.29e-05	5.28e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—KRAS—thyroid cancer	1.28e-05	5.24e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.28e-05	5.21e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.27e-05	5.2e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.27e-05	5.19e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—thyroid cancer	1.27e-05	5.18e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—thyroid cancer	1.27e-05	5.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NRAS—thyroid cancer	1.26e-05	5.13e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.25e-05	5.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—thyroid cancer	1.24e-05	5.06e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—thyroid cancer	1.24e-05	5.06e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.23e-05	5.03e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.23e-05	5.02e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.23e-05	5.01e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.23e-05	5.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.23e-05	5.01e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.22e-05	4.98e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.22e-05	4.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—thyroid cancer	1.21e-05	4.96e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—thyroid cancer	1.21e-05	4.96e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—thyroid cancer	1.21e-05	4.95e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTEN—thyroid cancer	1.21e-05	4.95e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—thyroid cancer	1.21e-05	4.95e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.21e-05	4.93e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.19e-05	4.88e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.19e-05	4.85e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.18e-05	4.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTEN—thyroid cancer	1.18e-05	4.82e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.18e-05	4.81e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.18e-05	4.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—thyroid cancer	1.17e-05	4.78e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.16e-05	4.74e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.16e-05	4.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.16e-05	4.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTEN—thyroid cancer	1.14e-05	4.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTEN—thyroid cancer	1.14e-05	4.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—thyroid cancer	1.13e-05	4.63e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—thyroid cancer	1.13e-05	4.63e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	4.57e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—thyroid cancer	1.09e-05	4.46e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—thyroid cancer	1.09e-05	4.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—thyroid cancer	1.08e-05	4.42e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	4.41e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.08e-05	4.4e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—thyroid cancer	1.07e-05	4.37e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—thyroid cancer	1.07e-05	4.37e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.06e-05	4.33e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.06e-05	4.32e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.06e-05	4.31e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.05e-05	4.31e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—thyroid cancer	1.05e-05	4.3e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—thyroid cancer	1.05e-05	4.3e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.05e-05	4.29e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.05e-05	4.29e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—thyroid cancer	1.05e-05	4.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—thyroid cancer	1.05e-05	4.27e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—thyroid cancer	1.04e-05	4.26e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.04e-05	4.25e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—thyroid cancer	1.03e-05	4.19e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—thyroid cancer	1.02e-05	4.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—thyroid cancer	9.95e-06	4.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—thyroid cancer	9.88e-06	4.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—thyroid cancer	9.88e-06	4.04e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—thyroid cancer	9.85e-06	4.03e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—thyroid cancer	9.65e-06	3.94e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	9.64e-06	3.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—thyroid cancer	9.62e-06	3.93e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—thyroid cancer	9.62e-06	3.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—thyroid cancer	9.61e-06	3.93e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—thyroid cancer	9.57e-06	3.91e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—thyroid cancer	9.53e-06	3.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—thyroid cancer	9.53e-06	3.9e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—thyroid cancer	9.38e-06	3.83e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—thyroid cancer	9.33e-06	3.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—thyroid cancer	9.3e-06	3.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—thyroid cancer	9.3e-06	3.8e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—thyroid cancer	9.26e-06	3.79e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—thyroid cancer	9.21e-06	3.76e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—thyroid cancer	9.18e-06	3.75e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—thyroid cancer	9.15e-06	3.74e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	9.12e-06	3.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—thyroid cancer	9.1e-06	3.72e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	8.97e-06	3.67e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	8.92e-06	3.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—thyroid cancer	8.89e-06	3.63e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—thyroid cancer	8.89e-06	3.63e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—thyroid cancer	8.79e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—thyroid cancer	8.78e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—thyroid cancer	8.5e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—thyroid cancer	8.5e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—thyroid cancer	8.5e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—thyroid cancer	8.5e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—thyroid cancer	8.42e-06	3.44e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—thyroid cancer	8.34e-06	3.41e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	8.29e-06	3.39e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—thyroid cancer	8.23e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.18e-06	3.34e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—thyroid cancer	8.11e-06	3.31e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—thyroid cancer	8.1e-06	3.31e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—thyroid cancer	8.08e-06	3.3e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—thyroid cancer	8.02e-06	3.28e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	7.92e-06	3.24e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	7.88e-06	3.22e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—thyroid cancer	7.87e-06	3.22e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—thyroid cancer	7.85e-06	3.21e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—thyroid cancer	7.85e-06	3.21e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	7.75e-06	3.17e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—thyroid cancer	7.73e-06	3.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—thyroid cancer	7.57e-06	3.09e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—thyroid cancer	7.44e-06	3.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	7.37e-06	3.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—thyroid cancer	7.32e-06	2.99e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—thyroid cancer	7.32e-06	2.99e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—thyroid cancer	7.13e-06	2.91e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	7.05e-06	2.88e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—thyroid cancer	6.98e-06	2.85e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—thyroid cancer	6.95e-06	2.84e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	6.84e-06	2.8e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—thyroid cancer	6.83e-06	2.79e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—thyroid cancer	6.79e-06	2.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—thyroid cancer	6.73e-06	2.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—thyroid cancer	6.57e-06	2.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—thyroid cancer	6.57e-06	2.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—thyroid cancer	6.51e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—thyroid cancer	6.51e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—thyroid cancer	6.43e-06	2.63e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—thyroid cancer	6.31e-06	2.58e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	6.22e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—thyroid cancer	6.22e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—thyroid cancer	6.22e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—thyroid cancer	5.91e-06	2.41e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—thyroid cancer	5.68e-06	2.32e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—thyroid cancer	5.5e-06	2.25e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—thyroid cancer	5.49e-06	2.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—thyroid cancer	5.49e-06	2.25e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—thyroid cancer	5.27e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—thyroid cancer	4.85e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—thyroid cancer	4.81e-06	1.97e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—thyroid cancer	4.11e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—thyroid cancer	3.17e-06	1.3e-05	CbGpPWpGaD
